nanoTherics | About nanoTherics

About nanoTherics

Nanotherics provide products addressing the field of magnetic nanoparticle research and applications. In particular we aim to be the number one supplier of products for nanoparticle heating applications utilizing AC field and solenoid coil principles.

We supply the magneTherm system which has been designed specifically for this purpose, operating at a wide range of frequencies (from 100 kHz to 1MHz) with field strengths up to 20 kA/m (25 mT) all in one system with no hidden extras needed.

Since the heating capacity of magnetic nanoparticles will vary, depending on size, shape and material properties, it is critical to be able to evaluate heating capacity (SAR/SLP/ILP) over as broad a range of frequencies as possible.

The magneTherm has undergone several design iterations and improvements during its lifetime and now represents a technologically adept solution for all magnetic nanoparticle heating applications.

The magneTherm covers all aspects and applications from calorimetry, in vitro, in vivo, drug delivery and release applications in a single, affordable solution – no need for multiple, expensive applicators, just a single system with multiple optional accessories that can expand the application range as required.

magneTherm

RC System – Software Controlled Option System – Manual Option InVivo System – Water Jacket Option High Field Strength Option Low Frequency Option LC-AMF Time-Lapse Imaging System Drug Release / Delivery Option External Coil Options Digital Option Accessories Consumables

Our Mission Statement

To design, build and market the most flexible and practical tools to enable our customers to perform cutting edge research. To provide flexible, well thought out, reliable and valued tools to our customers to further quality research in our chosen field.

To provide an innovative and aspirational culture for our employees, actively encouraging scientific collaboration with our customers in a customer centric environment ensuring a return for our investors.

Our People

The Future

Nanotherics are continually improving the magneTherm via discussions with our end users and engineers and development people, continually adding functionality to the system. We are currently developing several new accessories to expand application areas and will continue to advance this technology over the coming years.

Watch this space !

Carlton Jones – Chief Executive Officer

Carl has over 25 years of success in the life sciences commercial field. He has direct experience of developing sales and distribution channels across a range of disciplines within the global life sciences sector coupled with significant experience of implementing market penetration strategies for new products and technologies.

His prior position was with Thalesnano where he was responsible as Global Head of Sales for developing business with a disruptively innovative instrumentation and consumables range.

Previous roles include a variety of senior positions including Sales Director Europe, Middle East and Africa for Thermo Biosciences where he managed both direct and distribution channels, Managing Director at Affinity Sensors, an evanescent wave optical biosensor company, VP Sales and Marketing USA for Labsystems and various Business Development and Business Unit management roles in the life sciences instrumentation/consumables sector.

Jeremy Warren – Chairman

Jeremy Warren is a proven entrepreneur in the scientific research instrumentation sector, having lead analytical instrumentation business NanoSight Ltd, from founding through rapid international growth to a $25m exit.

He has wide experience at director level in VC-backed technology-lead SME business and is currently also chairman of Oxford Nanoimaging Ltd. Jeremy previously worked for Unilever in production management, before setting up a successful chemicals manufacturing business in Belgium. He also worked in strategy consultancy with Booz Allen.

Jeremy holds a degree in Chemical Engineering (Birmingham), an MBA (INSEAD) and is a chartered engineer.

Professor Jon Dobson – Founder/Director

Jon Dobson is Professor of Biomaterials and Biomedical Engineering at the University of Florida (UF), and was the Founding Director of the Institute for Cell and Tissue Science and Engineering (ICTSE) at UF.

He also holds an Honorary Professorship of Biophysics and Biomedical Engineering at Keele University in the UK. Professor Dobson has a B.Sc. and M.Sc. from the University of Florida, and a PhD from the Swiss Federal Institute of Technology, ETH-Zurich. He is a Fellow of the American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), The Royal Society of Biology, The Royal Society of Medicine, and a past Royal Society of London Wolfson Research Merit Fellow.

In 2002, Professor Dobson was selected for the Wellcome Trust’s Sir Henry Wellcome Showcase Award, and in 2008 the UK Medical Research Council’s César Milstein Award. He has published ~200 peer-reviewed scientific papers and is one of the most highly cited authors in the field of biomedical applications of magnetic nanoparticles. He is also co-founder of three spin-off companies, and holds 10 patents, with 10 more pending.

Brijesh Roy – Non-Executive Director representing Mercia

Brijesh is an Investment Manager at Mercia Technologies with a focus on finding and building technology companies based on research from universities.

Before Mercia, Brijesh spent five years at Isis Innovation, the technology commercialisation arm of Oxford University where he gained extensive experience in early stage technology, intellectual property, commercial licensing and raising investment. While at Isis, Brijesh led the launch of Europe’s biggest university spinout raising £12m to launch a gene therapy company in 2014.

Brijesh started his career in strategy consultancy at LEK where he received top-tier training in commercial research and strategic analysis. He gained investment experience on healthcare fund at Millennium Capital.

Brijesh holds a Masters from Oxford University and a PhD from University College London in Biochemical Neuroscience